Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers | NEJM - nejm.org

Correspondence from The New England Journal of Medicine — Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers

Data are needed regarding the effectiveness of a third dose of a messenger RNA (mRNA) vaccine against the B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) t… [+7207 chars]

full article...